129.7% Below Target

The consensus Wall Street price target for HNI is $95, representing 129.7% upside from the current price of $41.36. With 3 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

HNI has a consensus rating of "Buy" based on 3 Wall Street analysts. The rating breakdown is predominantly bullish, with 2 Buy/Strong Buy ratings. The consensus 12-month price target of $95 implies 129.7% upside from current levels.

With a forward P/E of 10.2822x, HNI trades at a relatively low valuation. The consensus target of $95 implies 129.7% appreciation, suggesting meaningful undervaluation.

The most bullish Wall Street analyst has a price target of $110 for HNI, while the most conservative target is $80. The consensus of $95 represents the median expectation. Our quantitative valuation model projects a bull case target of $53 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

HNI is lightly followed, with 3 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month HNI stock forecast based on 3 Wall Street analysts shows a consensus price target of $95, with estimates ranging from $80 (bear case) to $110 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $40, with bear/bull scenarios of $25/$53.

Our quantitative valuation model calculates HNI's fair value at $40 (base case), with a bear case of $25 and bull case of $53. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 44/100.

HNI trades at a forward P/E ratio of 10.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 37.3x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are very optimistic on HNI, with a "Buy" consensus rating and $95 price target (129.7% upside). 2 of 3 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

HNI analyst price targets range from $80 to $110, a 32% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $95 consensus represents the middle ground. Our model's $25-$53 range provides an independent fundamental perspective.